Genotype-phenotype correlation in the spectrum of frontotemporal dementia-parkinsonian syndromes and advanced diagnostic approaches

References

• Coyle-Gilchrist ITS, Dick KM, Patterson K, et al. Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology. 2016;86(18):1736–1743.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Piccininni M, Binetti G, et al. Incidence of frontotemporal lobar degeneration in Italy: the Salento-Brescia registry study. Neurology. 2019;92(20):e2355–e2363.
   PubMed Web of Science ®Google Scholar
• Piguet O, Kumfor F. Frontotemporal dementias: main syndromes and underlying brain changes. Curr Opin Neurol. 2020;33(2):215–221.
   PubMed Web of Science ®Google Scholar
• Ahmed RM, Hodges JR, Piguet O. Behavioural variant frontotemporal dementia: recent advances in the diagnosis and understanding of the disorder. Adv Exp Med Biol. 2021;1281:1–15.
   PubMed Web of Science ®Google Scholar
• Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(Pt 9):2456–2477.
   PubMed Web of Science ®Google Scholar
• Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006–1014.
   PubMed Web of Science ®Google Scholar
• Ferrari R, Kapogiannis D, Huey ED, et al. FTD and ALS: a tale of two diseases. Curr Alzheimer Res. 2011;8(3):273–294.
   PubMed Web of Science ®Google Scholar
• Hudson AJ. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. Brain. 1981;104(2):217–247.
   PubMed Web of Science ®Google Scholar
• Talbot PR. Frontal lobe dementia and motor neuron disease. J Neural Transm Suppl. 1996;47:125–132.
   PubMedGoogle Scholar
• Phukan J, Elamin M, Bede P, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2012;83(1):102–108.
   PubMed Web of Science ®Google Scholar
• Montuschi A, Iazzolino B, Calvo A, et al. Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry. 2015;86(2):168–173.
   PubMed Web of Science ®Google Scholar
• Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12(4):368–380.
   PubMed Web of Science ®Google Scholar
• Ringholz GM, Appel SH, Bradshaw M, et al. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65(4):586–590.
   PubMed Web of Science ®Google Scholar
• Burrell JR, Halliday GM, Kril JJ, et al. The frontotemporal dementia-motor neuron disease continuum. Lancet. 2016;388(10047):919–931.
   PubMed Web of Science ®Google Scholar
• Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130–133.
   PubMed Web of Science ®Google Scholar
• Geser F, Lee VM-Y, Trojanowski JQ. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies. Neuropathology. 2010;30(2):103–112.
   PubMed Web of Science ®Google Scholar
• Mackenzie IRA, Rademakers R. The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments. Neurogenetics. 2007;8(4):237–248.
   PubMed Web of Science ®Google Scholar
• Mackenzie IRA, Bigio EH, Ince PG, et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol. 2007;61(5):427–434.
   PubMed Web of Science ®Google Scholar
• Prudlo J, König J, Schuster C, et al. TDP-43 pathology and cognition in ALS: a prospective clinicopathologic correlation study. Neurology. 2016;87(10):1019–1023.
   PubMed Web of Science ®Google Scholar
• Gregory JM, McDade K, Bak TH, et al. Executive, language and fluency dysfunction are markers of localised TDP-43 cerebral pathology in non-demented ALS. J Neurol Neurosurg Psychiatry. 2020;91(2):149–157.
   PubMed Web of Science ®Google Scholar
• Barmada SJ, Finkbeiner S. Pathogenic TARDBP mutations in amyotrophic lateral sclerosis and frontotemporal dementia: disease-associated pathways. Rev Neurosci. 2010;21(4):251–272.
   PubMed Web of Science ®Google Scholar
• DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245–256.
   PubMed Web of Science ®Google Scholar
• Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257–268.
   PubMed Web of Science ®Google Scholar
• van der Zee J, Gijselinck I, Dillen L, et al. A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats. Hum Mutat. 2013;34(2):363–373.
   PubMed Web of Science ®Google Scholar
• Devenney E, Foxe D, Dobson-Stone C, et al. Clinical heterogeneity of the C9orf72 genetic mutation in frontotemporal dementia. Neurocase. 2015;21(4):535–541.
   PubMed Web of Science ®Google Scholar
• Irwin DJ, McMillan CT, Brettschneider J, et al. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2013;84(2):163–169.
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9(11):617–628.
   PubMed Web of Science ®Google Scholar
• Foster NL, Wilhelmsen K, Sima AA, et al. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference participants. Ann Neurol. 1997;41(6):706–715.
   PubMed Web of Science ®Google Scholar
• Spillantini MG, Murrell JR, Goedert M, et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA. 1998;95(13):7737–7741.
   PubMed Web of Science ®Google Scholar
• Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5’-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393(6686):702–705.
   PubMed Web of Science ®Google Scholar
• Spillantini MG, Van Swieten JC, Goedert M. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Neurogenetics. 2000;2(4):193–205.
   PubMed Web of Science ®Google Scholar
• Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442(7105):916–919.
   PubMed Web of Science ®Google Scholar
• Cruts M, Gijselinck I, van der Zee J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442(7105):920–924.
   PubMed Web of Science ®Google Scholar
• Younes K, Miller BL. Frontotemporal dementia: neuropathology, genetics, neuroimaging, and treatments. Psychiatr Clin North Am. 2020;43(2):331–344.
   PubMed Web of Science ®Google Scholar
• Onyike CU, Diehl-Schmid J. The epidemiology of frontotemporal dementia. Int Rev Psychiatry. 2013;25(2):130–137.
   PubMed Web of Science ®Google Scholar
• Rösler TW, Tayaranian Marvian A, Brendel M, et al. Four-repeat tauopathies. Prog Neurobiol. 2019;180:101644.
   PubMed Web of Science ®Google Scholar
• Goedert M, Spillantini MG, Jakes R, et al. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer’s disease. Neuron. 1989;3(4):519–526.
   PubMed Web of Science ®Google Scholar
• Wang Y, Mandelkow E. Tau in physiology and pathology. Nat Rev Neurosci. 2016;17(1):5–21.
   PubMed Web of Science ®Google Scholar
• Boeve BF, Boxer AL, Kumfor F, et al. Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations. Lancet Neurol. 2022;21(3):258–272.
   PubMed Web of Science ®Google Scholar
• Tuite PJ, Clark HB, Bergeron C, et al. Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy. Arch Neurol. 2005;62(9):1453–1457.
   PubMedGoogle Scholar
• Clark LN, Poorkaj P, Wszolek Z, et al. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci USA. 1998;95(22):13103–13107.
   PubMed Web of Science ®Google Scholar
• Poorkaj P, Bird TD, Wijsman E, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol. 1998;43(6):815–825.
   PubMed Web of Science ®Google Scholar
• Buée L, Bussière T, Buée-Scherrer V, et al. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev. 2000;33(1):95–130.
   PubMed Web of Science ®Google Scholar
• Goedert M, Spillantini MG, Potier MC, et al. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 1989;8(2):393–399.
   PubMed Web of Science ®Google Scholar
• Baizabal-Carvallo JF, Jankovic J. Parkinsonism, movement disorders and genetics in frontotemporal dementia. Nat Rev Neurol. 2016;12(3):175–185.
   PubMed Web of Science ®Google Scholar
• Hong M, Zhukareva V, Vogelsberg-Ragaglia V, et al. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science. 1998;282(5395):1914–1917.
   PubMed Web of Science ®Google Scholar
• Hasegawa M, Smith MJ, Goedert M. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett. 1998;437(3):207–210.
   PubMed Web of Science ®Google Scholar
• Houlden H, Baker M, Adamson J, et al. Frequency of tau mutations in three series of non-Alzheimer’s degenerative dementia. Ann Neurol. 1999;46(2):243–248.
   PubMed Web of Science ®Google Scholar
• Poorkaj P, Grossman M, Steinbart E, et al. Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neurol. 2001;58(3):383–387.
   PubMedGoogle Scholar
• Rizzu P, Van Swieten JC, Joosse M, et al. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in The Netherlands. Am J Hum Genet. 1999;64(2):414–421.
   PubMed Web of Science ®Google Scholar
• Binetti G, Nicosia F, Benussi L, et al. Prevalence of TAU mutations in an Italian clinical series of familial frontotemporal patients. Neurosci Lett. 2003;338(1):85–87.
   PubMed Web of Science ®Google Scholar
• Kaivorinne AL, Krüger J, Kuivaniemi K, et al. Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland. BMC Neurol. 2008;8:48.
   PubMed Web of Science ®Google Scholar
• Pickering-Brown SM, Rollinson S, Du Plessis D, et al. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain. 2008;131(Pt 3):721–731.
   PubMedGoogle Scholar
• Rademakers R, Cruts M, van Broeckhoven C. The role of tau (MAPT) in frontotemporal dementia and related tauopathies. Hum Mutat. 2004;24(4):277–295.
   PubMed Web of Science ®Google Scholar
• Snowden JS, Adams J, Harris J, et al. Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7–8):497–505.
   PubMed Web of Science ®Google Scholar
• Seelaar H, Rohrer JD, Pijnenburg YAL, et al. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry. 2011;82(5):476–486.
   PubMed Web of Science ®Google Scholar
• Moore KM, Nicholas J, Grossman M, et al. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. Lancet Neurol. 2020;19(2):145–156.
   PubMed Web of Science ®Google Scholar
• Domoto-Reilly K, Davis MY, Keene CD, et al. Unusually long duration and delayed penetrance in a family with FTD and mutation in MAPT (V337M). Am J Med Genet B Neuropsychiatr Genet. 2017;174(1):70–74.
   PubMed Web of Science ®Google Scholar
• Sun L, Chen K, Li X, et al. Rapidly progressive frontotemporal dementia associated with MAPT mutation G389R. J Alzheimers Dis. 2017;55(2):777–785.
   PubMed Web of Science ®Google Scholar
• van Herpen E, Rosso SM, Serverijnen LA, et al. Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R. Ann Neurol. 2003;54(5):573–581.
   PubMed Web of Science ®Google Scholar
• Boeve BF, Tremont-Lukats IW, Waclawik AJ, et al. Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation. Brain. 2005;128(Pt 4):752–772.
   PubMedGoogle Scholar
• Bugiani O, Murrell JR, Giaccone G, et al. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol. 1999;58(6):667–677.
   PubMed Web of Science ®Google Scholar
• Janssen JC, Warrington EK, Morris HR, et al. Clinical features of frontotemporal dementia due to the intronic tau 10(+16) mutation. Neurology. 2002;58(8):1161–1168.
   PubMed Web of Science ®Google Scholar
• van Swieten JC, Stevens M, Rosso SM, et al. Phenotypic variation in hereditary frontotemporal dementia with tau mutations. Ann Neurol. 1999;46(4):617–626.
   PubMed Web of Science ®Google Scholar
• Wszolek ZK, Tsuboi Y, Farrer M, et al. Hereditary tauopathies and Parkinsonism. Adv Neurol. 2003;91:153–163.
   Google Scholar
• Munoz DG, Ros R, Fatas M, et al. Progressive nonfluent aphasia associated with a new mutation V363I in tau gene. Am J Alzheimers Dis Other Demen. 2007;22(4):294–299.
   PubMedGoogle Scholar
• Rohrer JD, Guerreiro R, Vandrovcova J, et al. The heritability and genetics of frontotemporal lobar degeneration. Neurology. 2009;73(18):1451–1456.
   PubMed Web of Science ®Google Scholar
• Baba Y, Baker MC, Le Ber I, et al. Clinical and genetic features of families with frontotemporal dementia and Parkinsonism linked to chromosome 17 with a P301S tau mutation. J Neural Transm (Vienna). 2007;114(7):947–950.
   PubMed Web of Science ®Google Scholar
• Kouri N, Carlomagno Y, Baker M, et al. Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration. Acta Neuropathol. 2014;127(2):271–282.
   PubMed Web of Science ®Google Scholar
• Rohrer JD, Warren JD. Phenotypic signatures of genetic frontotemporal dementia. Curr Opin Neurol. 2011;24(6):542–549.
   PubMed Web of Science ®Google Scholar
• Spina S, Farlow MR, Unverzagt FW, et al. The tauopathy associated with mutation +3 in intron 10 of tau: characterization of the MSTD family. Brain. 2008;131(Pt 1):72–89.
   PubMedGoogle Scholar
• van Swieten J, Spillantini MG. Hereditary frontotemporal dementia caused by tau gene mutations. Brain Pathol. 2007;17(1):63–73.
   PubMed Web of Science ®Google Scholar
• Bessi V, Bagnoli S, Nacmias B, et al. Semantic dementia associated with mutation V363I in the tau gene. J Neurol Sci. 2010;296(1–2):112–114.
   PubMed Web of Science ®Google Scholar
• Ishizuka T, Nakamura M, Ichiba M, et al. Familial semantic dementia with P301L mutation in the tau gene. Dement Geriatr Cogn Disord. 2011;31(5):334–340.
   PubMed Web of Science ®Google Scholar
• Villa C, Ghezzi L, Pietroboni AM, et al. A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia. J Alzheimers Dis. 2011;26(1):19–26.
   PubMed Web of Science ®Google Scholar
• Rohrer JD, Paviour D, Vandrovcova J, et al. Novel L284R MAPT mutation in a family with an autosomal dominant progressive supranuclear palsy syndrome. Neurodegener Dis. 2011;8(3):149–152.
   PubMed Web of Science ®Google Scholar
• Reed LA, Grabowski TJ, Schmidt ML, et al. Autosomal dominant dementia with widespread neurofibrillary tangles. Ann Neurol. 1997;42(4):564–572.
   PubMed Web of Science ®Google Scholar
• Tolboom N, Koedam ELGE, Schott JM, et al. Dementia mimicking alzheimer’s disease owing to a tau mutation: CSF and PET findings. Alzheimer Dis Assoc Disord. 2010;24(3):303–307.
   PubMed Web of Science ®Google Scholar
• Rovelet-Lecrux A, Hannequin D, Guillin O, et al. Frontotemporal dementia phenotype associated with MAPT gene duplication. J Alzheimers Dis. 2010;21(3):897–902.
   PubMed Web of Science ®Google Scholar
• Behnam M, Ghorbani F, Shin J-H, et al. Homozygous MAPT R406W mutation causing FTDP phenotype: a unique instance of a unique mutation. Gene. 2015;570(1):150–152.
   PubMed Web of Science ®Google Scholar
• Ng ASL, Sias AC, Pressman PS, et al. Young-onset frontotemporal dementia in a homozygous tau R406W mutation carrier. Ann Clin Transl Neurol. 2015;2(12):1124–1128.
   PubMed Web of Science ®Google Scholar
• Carney RM, Kohli MA, Kunkle BW, et al. Parkinsonism and distinct dementia patterns in a family with the MAPT R406W mutation. Alzheimers Dement. 2014;10(3):360–365.
   PubMed Web of Science ®Google Scholar
• Ygland E, van Westen D, Englund E, et al. Slowly progressive dementia caused by MAPT R406W mutations: longitudinal report on a new kindred and systematic review. Alzheimers Res Ther. 2018;10(1):2.
   PubMedGoogle Scholar
• Ghetti B, Oblak AL, Boeve BF, et al. Invited review: frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging. Neuropathol Appl Neurobiol. 2015;41(1):24–46.
   PubMed Web of Science ®Google Scholar
• Tsuboi Y, Baker M, Hutton ML, et al. Clinical and genetic studies of families with the tau N279K mutation (FTDP-17). Neurology. 2002;59(11):1791–1793.
   PubMed Web of Science ®Google Scholar
• Coppola G, Chinnathambi S, Lee JJ, et al. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer’s diseases. Hum Mol Genet. 2012;21(15):3500–3512.
   PubMed Web of Science ®Google Scholar
• Labbé C, Ogaki K, Lorenzo-Betancor O, et al. Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies. Neurology. 2015;85(19):1680–1686.
   PubMed Web of Science ®Google Scholar
• Lee SE, Tartaglia MC, Yener G, et al. Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease. Alzheimer Dis Assoc Disord. 2013;27(4):302–309.
   PubMed Web of Science ®Google Scholar
• Di Maria E, Tabaton M, Vigo T, et al. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann Neurol. 2000;47(3):374–377.
   PubMed Web of Science ®Google Scholar
• Houlden H, Baker M, Morris HR, et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology. 2001;56(12):1702–1706.
   PubMed Web of Science ®Google Scholar
• Gass J, Cannon A, Mackenzie IR, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet. 2006;15(20):2988–3001.
   PubMed Web of Science ®Google Scholar
• Daniel R, Daniels E, He Z, et al. Progranulin (acrogranin/PC cell-derived growth factor/granulin-epithelin precursor) is expressed in the placenta, epidermis, microvasculature, and brain during murine development. Dev Dyn. 2003;227(4):593–599.
   PubMed Web of Science ®Google Scholar
• He Z, Bateman A. Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo. Cancer Res. 1999;59(13):3222–3229.
   PubMed Web of Science ®Google Scholar
• Kessenbrock K, Fröhlich L, Sixt M, et al. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J Clin Invest. 2008;118(7):2438–2447.
   PubMed Web of Science ®Google Scholar
• Xu SQ, Tang D, Chamberlain S, et al. The granulin/epithelin precursor abrogates the requirement for the insulin-like growth factor 1 receptor for growth in vitro. J Biol Chem. 1998;273(32):20078–20083.
   PubMed Web of Science ®Google Scholar
• Chen-Plotkin AS, Martinez-Lage M, Sleiman PMA, et al. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch Neurol. 2011;68(4):488–497.
   PubMedGoogle Scholar
• Gijselinck I, Van Broeckhoven C, Cruts M. Granulin mutations associated with frontotemporal lobar degeneration and related disorders: an update. Hum Mutat. 2008;29(12):1373–1386.
   PubMed Web of Science ®Google Scholar
• Rademakers R, Baker M, Gass J, et al. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C–>T (Arg493X) mutation: an international initiative. Lancet Neurol. 2007;6(10):857–868.
   PubMed Web of Science ®Google Scholar
• van der Zee J, Rademakers R, Engelborghs S, et al. A belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. Brain. 2006;129(Pt 4):841–852.
   PubMedGoogle Scholar
• Bagnoli S, Piaceri I, Tedde A, et al. Progranulin genetic screening in frontotemporal lobar degeneration patients from Central Italy. Cell Mol Neurobiol. 2012;32(1):13–16.
   PubMed Web of Science ®Google Scholar
• Benussi L, Ghidoni R, Binetti G. Progranulin mutations are a common cause of FTLD in Northern Italy. Alzheimer Dis Assoc Disord. 2010;24(3):308–309.
   PubMed Web of Science ®Google Scholar
• Benussi L, Ghidoni R, Pegoiani E, et al. Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide. Neurobiol Dis. 2009;33(3):379–385.
   PubMed Web of Science ®Google Scholar
• Gossye H, Van Broeckhoven C, Engelborghs S. The use of biomarkers and genetic screening to diagnose frontotemporal dementia: evidence and clinical implications. Front Neurosci. 2019;13:757.
   PubMed Web of Science ®Google Scholar
• Beck J, Rohrer JD, Campbell T, et al. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain. 2008;131(Pt 3):706–720.
   PubMedGoogle Scholar
• Le Ber I, van der Zee J, Hannequin D, et al. Progranulin null mutations in both sporadic and familial frontotemporal dementia. Hum Mutat. 2007;28(9):846–855.
   PubMed Web of Science ®Google Scholar
• Goldman JS, Rademakers R, Huey ED, et al. An algorithm for genetic testing of frontotemporal lobar degeneration. Neurology. 2011;76(5):475–483.
   PubMed Web of Science ®Google Scholar
• Le Ber I, Camuzat A, Hannequin D, et al. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain. 2008;131(Pt 3):732–746.
   PubMedGoogle Scholar
• Josephs KA, Ahmed Z, Katsuse O, et al. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol. 2007;66(2):142–151.
   PubMed Web of Science ®Google Scholar
• Mesulam M, Johnson N, Krefft TA, et al. Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Arch Neurol. 2007;64(1):43–47.
   PubMedGoogle Scholar
• Snowden JS, Pickering-Brown SM, Mackenzie IR, et al. Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia. Brain. 2006;129(Pt 11):3091–3102.
   PubMedGoogle Scholar
• Van Mossevelde S, Engelborghs S, van der Zee J, et al. Genotype-phenotype links in frontotemporal lobar degeneration. Nat Rev Neurol. 2018;14(6):363–378.
   PubMed Web of Science ®Google Scholar
• Irwin DJ, Cairns NJ, Grossman M, et al. Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine. Acta Neuropathol. 2015;129(4):469–491.
   PubMed Web of Science ®Google Scholar
• Benussi L, Binetti G, Sina E, et al. A novel deletion in progranulin gene is associated with FTDP-17 and CBS. Neurobiol Aging. 2008;29(3):427–435.
   PubMed Web of Science ®Google Scholar
• Guerreiro RJ, Santana I, Bras JM, et al. Novel progranulin mutation: screening for PGRN mutations in a Portuguese series of FTD/CBS cases. Mov Disord. 2008;23(9):1269–1273.
   PubMed Web of Science ®Google Scholar
• López de Munain A, Alzualde A, Gorostidi A, et al. Mutations in progranulin gene: clinical, pathological, and ribonucleic acid expression findings. Biol Psychiatry. 2008;63(10):946–952.
   PubMed Web of Science ®Google Scholar
• Masellis M, Momeni P, Meschino W, et al. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain. 2006;129(Pt 11):3115–3123.
   PubMedGoogle Scholar
• Spina S, Murrell JR, Huey ED, et al. Corticobasal syndrome associated with the A9D progranulin mutation. J Neuropathol Exp Neurol. 2007;66(10):892–900.
   PubMed Web of Science ®Google Scholar
• van der Ende EL, Jackson JL, White A, et al. Unravelling the clinical spectrum and the role of repeat length in C9ORF72 repeat expansions. J Neurol Neurosurg Psychiatry. 2021;92(5):502–509.
   PubMed Web of Science ®Google Scholar
• Gijselinck I, Van Langenhove T, van der Zee J, et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol. 2012;11(1):54–65.
   PubMed Web of Science ®Google Scholar
• Gijselinck I, Cruts M, Van Broeckhoven C. The genetics of C9orf72 expansions. Cold Spring Harb Perspect Med. 2018;8(4):a026757.
   PubMed Web of Science ®Google Scholar
• Gijselinck I, Van Mossevelde S, van der Zee J, et al. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter. Mol Psychiatry. 2016;21(8):1112–1124.
   PubMed Web of Science ®Google Scholar
• Sieben A, Van Langenhove T, Engelborghs S, et al. The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol. 2012;124(3):353–372.
   PubMed Web of Science ®Google Scholar
• Rademakers R, Neumann M, Mackenzie IR. Advances in understanding the molecular basis of frontotemporal dementia. Nat Rev Neurol. 2012;8(8):423–434.
   PubMed Web of Science ®Google Scholar
• Majounie E, Renton AE, Mok K, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012;11(4):323–330.
   PubMed Web of Science ®Google Scholar
• Beck J, Poulter M, Hensman D, et al. Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am J Hum Genet. 2013;92(3):345–353.
   PubMed Web of Science ®Google Scholar
• Benussi L, Rossi G, Glionna M, et al. C9ORF72 hexanucleotide repeat number in frontotemporal lobar degeneration: a genotype-phenotype correlation study. J Alzheimers Dis. 2014;38(4):799–808.
   PubMed Web of Science ®Google Scholar
• Mahoney CJ, Beck J, Rohrer JD, et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain. 2012;135(Pt 3):736–750.
   PubMed Web of Science ®Google Scholar
• Van Mossevelde S, van der Zee J, Gijselinck I, et al. Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort. Brain. 2016;139(Pt 2):452–467.
   PubMedGoogle Scholar
• Van Mossevelde S, van der Zee J, Gijselinck I, et al. Clinical evidence of disease anticipation in families segregating a C9orf72 repeat expansion. JAMA Neurol. 2017;74(4):445–452.
   PubMed Web of Science ®Google Scholar
• Boeve BF, Boylan KB, Graff-Radford NR, et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain. 2012;135(Pt 3):765–783.
   PubMedGoogle Scholar
• Hsiung GYR, DeJesus-Hernandez M, Feldman HH, et al. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. Brain. 2012;135(Pt 3):709–722.
   PubMedGoogle Scholar
• Van Mossevelde S, van der Zee J, Cruts M, et al. Relationship between C9orf72 repeat size and clinical phenotype. Curr Opin Genet Dev. 2017;44:117–124.
   PubMed Web of Science ®Google Scholar
• Rohrer JD, Isaacs AM, Mizielinska S, et al. C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. Lancet Neurol. 2015;14(3):291–301.
   PubMed Web of Science ®Google Scholar
• Snowden JS, Rollinson S, Thompson JC, et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain. 2012;135(Pt 3):693–708.
   PubMed Web of Science ®Google Scholar
• Dobson-Stone C, Hallupp M, Bartley L, et al. C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts. Neurology. 2012;79(10):995–1001.
   PubMed Web of Science ®Google Scholar
• Devenney E, Hornberger M, Irish M, et al. Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile. JAMA Neurol. 2014;71(3):331–339.
   PubMed Web of Science ®Google Scholar
• Sha SJ, Takada LT, Rankin KP, et al. Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features. Neurology. 2012;79(10):1002–1011.
   PubMed Web of Science ®Google Scholar
• Saint-Aubert L, Sagot C, Wallon D, et al. A case of logopenic primary progressive aphasia with C9ORF72 expansion and cortical florbetapir binding. J Alzheimers Dis. 2014;42(2):413–420.
   PubMed Web of Science ®Google Scholar
• Simón-Sánchez J, Dopper EGP, Cohn-Hokke PE, et al. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. Brain. 2012;135(Pt 3):723–735.
   PubMedGoogle Scholar
• Galimberti D, Fenoglio C, Serpente M, et al. Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation. Biol Psychiatry. 2013;74(5):384–391.
   PubMed Web of Science ®Google Scholar
• Lesage S, Le Ber I, Condroyer C, et al. C9orf72 repeat expansions are a rare genetic cause of Parkinsonism. Brain. 2013;136(Pt 2):385–391.
   PubMedGoogle Scholar
• Lindquist SG, Duno M, Batbayli M, et al. Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease. Clin Genet. 2013;83(3):279–283.
   PubMed Web of Science ®Google Scholar
• Cali CP, Patino M, Tai YK, et al. C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy. Acta Neuropathol. 2019;138(5):795–811.
   PubMed Web of Science ®Google Scholar
• Watts GDJ, Wymer J, Kovach MJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004;36(4):377–381.
   PubMed Web of Science ®Google Scholar
• Nalbandian A, Donkervoort S, Dec E, et al. The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget’s disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis. J Mol Neurosci. 2011;45(3):522–531.
   PubMed Web of Science ®Google Scholar
• Matsubara T, Izumi Y, Oda M, et al. An autopsy report of a familial amyotrophic lateral sclerosis case carrying VCP Arg487His mutation with a unique TDP-43 proteinopathy. Neuropathology. 2021;41(2):118–126.
   PubMed Web of Science ®Google Scholar
• Gonzalez MA, Feely SM, Speziani F, et al. A novel mutation in VCP causes Charcot-Marie-Tooth type 2 disease. Brain. 2014;137(Pt 11):2897–2902.
   PubMed Web of Science ®Google Scholar
• van de Warrenburg BP, Schouten MI, de Bot ST, et al. Clinical exome sequencing for cerebellar ataxia and spastic paraplegia uncovers novel gene-disease associations and unanticipated rare disorders. Eur J Hum Genet. 2016;24(10):1460–1466.
   PubMed Web of Science ®Google Scholar
• van der Zee J, Pirici D, Van Langenhove T, et al. Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His. Neurology. 2009;73(8):626–632.
   PubMed Web of Science ®Google Scholar
• Kovach MJ, Waggoner B, Leal SM, et al. Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol Genet Metab. 2001;74(4):458–475.
   PubMed Web of Science ®Google Scholar
• Guyant-Maréchal L, Laquerrière A, Duyckaerts C, et al. Valosin-containing protein gene mutations: clinical and neuropathologic features. Neurology. 2006;67(4):644–651.
   PubMed Web of Science ®Google Scholar
• Jacquin A, Rouaud O, Soichot P, et al. Psychiatric presentation of frontotemporal dementia associated with inclusion body myopathy due to the VCP mutation (R155H) in a french family. Case Rep Neurol. 2013;5(3):187–194.
   PubMedGoogle Scholar
• Siuda J, Fujioka S, Wszolek ZK. Parkinsonian syndrome in familial frontotemporal dementia. Parkinsonism Relat Disord. 2014;20(9):957–964.
   PubMed Web of Science ®Google Scholar
• Spina S, Van Laar AD, Murrell JR, et al. Phenotypic variability in three families with valosin-containing protein mutation. Eur J Neurol. 2013;20(2):251–258.
   PubMed Web of Science ®Google Scholar
• Mehta SG, Khare M, Ramani R, et al. Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia. Clin Genet. 2013;83(5):422–431.
   PubMed Web of Science ®Google Scholar
• González-Pérez P, Cirulli ET, Drory VE, et al. Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis. Neurology. 2012;79(22):2201–2208.
   PubMed Web of Science ®Google Scholar
• Cirulli ET, Lasseigne BN, Petrovski S, et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347(6229):1436–1441.
   PubMed Web of Science ®Google Scholar
• Freischmidt A, Wieland T, Richter B, et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci. 2015;18(5):631–636.
   PubMed Web of Science ®Google Scholar
• Weidberg H, Elazar Z. TBK1 mediates crosstalk between the innate immune response and autophagy. Sci Signal. 2011;4(187):pe39.
   PubMed Web of Science ®Google Scholar
• Maruyama H, Morino H, Ito H, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465(7295):223–226.
   PubMed Web of Science ®Google Scholar
• Fecto F, Yan J, Vemula SP, et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol. 2011;68(11):1440–1446.
   PubMedGoogle Scholar
• Caroppo P, Camuzat A, De Septenville A, et al. Semantic and nonfluent aphasic variants, secondarily associated with amyotrophic lateral sclerosis, are predominant frontotemporal lobar degeneration phenotypes in TBK1 carriers. Alzheimers Dement (Amst). 2015;1(4):481–486.
   PubMedGoogle Scholar
• Gijselinck I, Van Mossevelde S, van der Zee J, et al. Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort. Neurology. 2015;85(24):2116–2125.
   PubMed Web of Science ®Google Scholar
• Wilke C, Baets J, De Bleecker JL, et al. Beyond ALS and FTD: the phenotypic spectrum of TBK1 mutations includes PSP-like and cerebellar phenotypes. Neurobiol Aging. 2018;62:244.e9-244–e13.
   Web of Science ®Google Scholar
• Kabashi E, Valdmanis PN, Dion P, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008;40(5):572–574.
   PubMed Web of Science ®Google Scholar
• Sreedharan J, Blair IP, Tripathi VB, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319(5870):1668–1672.
   PubMed Web of Science ®Google Scholar
• Van Deerlin VM, Leverenz JB, Bekris LM, et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008;7(5):409–416.
   PubMed Web of Science ®Google Scholar
• Benajiba L, Le Ber I, Camuzat A, et al. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol. 2009;65(4):470–473.
   PubMed Web of Science ®Google Scholar
• Cheng YW, Lee MJ, Chen TF, et al. A single nucleotide TDP-43 mutation within a Taiwanese family: a multifaceted demon. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(3–4):292–294.
   PubMed Web of Science ®Google Scholar
• González-Sánchez M, Puertas-Martín V, Esteban-Pérez J, et al. TARDBP mutation associated with semantic variant primary progressive aphasia, case report and review of the literature. Neurocase. 2018;24(5–6):301–305.
   PubMed Web of Science ®Google Scholar
• Floris G, Borghero G, Cannas A, et al. Clinical phenotypes and radiological findings in frontotemporal dementia related to TARDBP mutations. J Neurol. 2015;262(2):375–384.
   PubMed Web of Science ®Google Scholar
• Caroppo P, Camuzat A, Guillot-Noel L, et al. Defining the spectrum of frontotemporal dementias associated with TARDBP mutations. Neurol Genet. 2016;2(3):e80.
   PubMedGoogle Scholar
• Chiò A, Calvo A, Moglia C, et al. Amyotrophic lateral sclerosis-frontotemporal lobar dementia in 3 families with p.Ala382Thr TARDBP mutations. Arch Neurol. 2010;67(8):1002–1009.
   PubMedGoogle Scholar
• Cannas A, Borghero G, Floris GL, et al. The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson’s disease and other degenerative parkinsonisms. Neurogenetics. 2013;14(2):161–166.
   PubMed Web of Science ®Google Scholar
• Rayaprolu S, Fujioka S, Traynor S, et al. TARDBP mutations in Parkinson’s disease. Parkinsonism Relat Disord. 2013;19(3):312–315.
   PubMed Web of Science ®Google Scholar
• Van Langenhove T, van der Zee J, Sleegers K, et al. Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology. 2010;74(5):366–371.
   PubMed Web of Science ®Google Scholar
• Huey ED, Ferrari R, Moreno JH, et al. FUS and TDP43 genetic variability in FTD and CBS. Neurobiol Aging. 2012;33(5):1016.e9-17–1016.17.
   PubMed Web of Science ®Google Scholar
• Neumann M, Rademakers R, Roeber S, et al. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain. 2009;132(Pt 11):2922–2931.
   PubMed Web of Science ®Google Scholar
• Urwin H, Josephs KA, Rohrer JD, et al. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol. 2010;120(1):33–41.
   PubMed Web of Science ®Google Scholar
• Spillantini MG, Goedert M. Tau pathology and neurodegeneration. Lancet Neurol. 2013;12(6):609–622.
   PubMed Web of Science ®Google Scholar
• Ward ME, Chen R, Huang H-Y, et al. Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis. Sci Transl Med. 2017;9:eaah5642.
   PubMed Web of Science ®Google Scholar
• Braems E, Swinnen B, Van Den Bosch L. C9orf72 loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS/FTD? Acta Neuropathol. 2020;140(5):625–643.
   PubMed Web of Science ®Google Scholar
• Gitcho MA, Bigio EH, Mishra M, et al. TARDBP 3’-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy. Acta Neuropathol. 2009;118(5):633–645.
   PubMed Web of Science ®Google Scholar
• White MA, Kim E, Duffy A, et al. TDP-43 gains function due to perturbed autoregulation in a tardbp knock-in mouse model of ALS-FTD. Nat Neurosci. 2018;21(4):552–563.
   PubMed Web of Science ®Google Scholar
• Scekic-Zahirovic J, Sendscheid O, El Oussini H, et al. Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss. EMBO J. 2016;35(10):1077–1097.
   PubMed Web of Science ®Google Scholar
• Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461(7265):747–753.
   PubMed Web of Science ®Google Scholar
• Ferrari R, Hernandez DG, Nalls MA, et al. Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurol. 2014;13(7):686–699.
   PubMed Web of Science ®Google Scholar
• Ferrari R, Grassi M, Salvi E, et al. A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia. Neurobiol Aging. 2015;36(10):2904.e13-26–2904.e26.
   PubMed Web of Science ®Google Scholar
• Diekstra FP, Van Deerlin VM, van Swieten JC, et al. C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis. Ann Neurol. 2014;76(1):120–133.
   PubMed Web of Science ®Google Scholar
• de Leeuw CA, Mooij JM, Heskes T, et al. MAGMA: generalized gene-set analysis of GWAS data. PloS Comput Biol. 2015;11(4):e1004219.
   PubMed Web of Science ®Google Scholar
• Mishra A, Ferrari R, Heutink P, et al. Gene-based association studies report genetic links for clinical subtypes of frontotemporal dementia. Brain. 2017;140(5):1437–1446.
   PubMedGoogle Scholar
• Ferrari R, Wang Y, Vandrovcova J, et al. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer’s and Parkinson’s diseases. J Neurol Neurosurg Psychiatry. 2017;88(2):152–164.
   PubMed Web of Science ®Google Scholar
• Pottier C, Zhou X, Perkerson RB, et al. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. Lancet Neurol. 2018;17(6):548–558.
   PubMed Web of Science ®Google Scholar
• Pottier C, Ren Y, Perkerson RB, et al. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD. Acta Neuropathol. 2019;137(6):879–899.
   PubMed Web of Science ®Google Scholar
• Reus LM, Pasaniuc B, Posthuma D, et al. Gene expression imputation across multiple tissue types provides insight into the genetic architecture of frontotemporal dementia and its clinical subtypes. Biol Psychiatry. 2021;89(8):825–835.
   PubMed Web of Science ®Google Scholar
• Bean LJH, Funke B, Carlston CM, et al. Diagnostic gene sequencing panels: from design to report-a technical standard of the American college of medical genetics and genomics (ACMG). Genet Med. 2020;22(3):453–461.
   PubMed Web of Science ®Google Scholar
• Boycott KM, Vanstone MR, Bulman DE, et al. Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat Rev Genet. 2013;14(10):681–691.
   PubMed Web of Science ®Google Scholar
• van der Zee J, Van Langenhove T, Kovacs GG, et al. Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration. Acta Neuropathol. 2014;128(3):397–410.
   PubMed Web of Science ®Google Scholar
• Baradaran-Heravi Y, Van Broeckhoven C, van der Zee J. Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum. Neurobiol Dis. 2020;134:104639.
   PubMed Web of Science ®Google Scholar
• Ciani M, Benussi L, Bonvicini C, et al. Genome wide association study and next generation sequencing: a glimmer of light toward new possible horizons in frontotemporal dementia research. Front Neurosci. 2019;13:506.
   PubMed Web of Science ®Google Scholar
• Moreno F, Indakoetxea B, Barandiaran M, et al. The unexpected co-occurrence of GRN and MAPT p.A152T in basque families: clinical and pathological characteristics. PloS One. 2017;12(6):e0178093.
   PubMed Web of Science ®Google Scholar
• Wauters E, Van Mossevelde S, Sleegers K, et al. Clinical variability and onset age modifiers in an extended Belgian GRN founder family. Neurobiol Aging. 2018;67:84–94.
   PubMed Web of Science ®Google Scholar
• Bottero V, Alrafati F, Santiago JA, et al. Transcriptomic and network Meta-Analysis of frontotemporal dementias. Front Mol Neurosci. 2021;14:747798.
   PubMed Web of Science ®Google Scholar
• van der Ende EL, Meeter LH, Stingl C, et al. Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomics. Ann Clin Transl Neurol. 2019;6(4):698–707.
   PubMed Web of Science ®Google Scholar
• Szebényi K, Wenger LMD, Sun Y, et al. Human ALS/FTD brain organoid slice cultures display distinct early astrocyte and targetable neuronal pathology. Nat Neurosci. 2021;24(11):1542–1554.
   PubMed Web of Science ®Google Scholar
• Bowles KR, Silva MC, Whitney K, et al. ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids. Cell. 2021;184(17):4547–4563.e17.
   PubMed Web of Science ®Google Scholar
• Ramos EM, Dokuru DR, Van Berlo V, et al. Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases. Alzheimers Dement. 2020;16(1):118–130.
   PubMed Web of Science ®Google Scholar
• Rohrer JD, Nicholas JM, Cash DM, et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the genetic frontotemporal dementia initiative (GENFI) study: a cross-sectional analysis. Lancet Neurol. 2015;14(3):253–262.
   PubMed Web of Science ®Google Scholar
• Boeve B, Bove J, Brannelly P, et al. The longitudinal evaluation of familial frontotemporal dementia subjects protocol: framework and methodology. Alzheimers Dement. 2020;16(1):22–36.
   PubMed Web of Science ®Google Scholar
• Borroni B, Graff C, Hardiman O, et al. FRONTotemporal dementia incidence European research study-FRONTIERS: rationale and design. Alzheimers Dement. 2022;18(3):498–506.
   PubMed Web of Science ®Google Scholar